DB17771InvestigationalProtein Based Therapies
Sevirumab: Overview.
- Also known as
- IMMUNOGLOBULIN G1, ANTI-(CYTOMEGALOVIRUS) (HUMAN MONOCLONAL EV2-7 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL EV2-7 .KAPPA.-CHAIN, DIMER · SDZ MSL 109 · SDZ-MSL-109
- Code names
- EV2-7 · MSL-109
Resolves to
Compound
What you can answer from here — as of July 18, 2023
Which companies are running trials of Sevirumab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account